832 related articles for article (PubMed ID: 28213269)
21. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
[TBL] [Abstract][Full Text] [Related]
22. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of protostemonine on LPS/GalN-induced acute liver failure: Roles of increased hepatic expression of heme oxygenase-1.
Cheng Z; Yue L; Zhao W; Yang X; Shu G
Int Immunopharmacol; 2015 Dec; 29(2):798-807. PubMed ID: 26363973
[TBL] [Abstract][Full Text] [Related]
24. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
Zhu Y; Chen X; Rao X; Zheng C; Peng X
Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
[TBL] [Abstract][Full Text] [Related]
26. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H
Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756
[TBL] [Abstract][Full Text] [Related]
27. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
Li Z; Feng H; Wang Y; Shen B; Tian Y; Wu L; Zhang Q; Jin M; Liu G
Int Immunopharmacol; 2019 Feb; 67():465-472. PubMed ID: 30597292
[TBL] [Abstract][Full Text] [Related]
28. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
Tang F; Fan K; Wang K; Bian C
Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
[TBL] [Abstract][Full Text] [Related]
29. Panaxynol from
Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
[TBL] [Abstract][Full Text] [Related]
30. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice.
Gong X; Yang Y; Huang L; Zhang Q; Wan RZ; Zhang P; Zhang B
Int Immunopharmacol; 2017 May; 46():124-132. PubMed ID: 28282576
[TBL] [Abstract][Full Text] [Related]
31. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis.
Lv H; An B; Yu Q; Cao Y; Liu Y; Li S
Int J Biol Macromol; 2020 Jul; 155():1092-1104. PubMed ID: 31712142
[TBL] [Abstract][Full Text] [Related]
32. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
[TBL] [Abstract][Full Text] [Related]
33. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
34. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.
Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X
Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of ginsenoside Rg1 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway.
Ning C; Gao X; Wang C; Huo X; Liu Z; Sun H; Yang X; Sun P; Ma X; Meng Q; Liu K
Int Immunopharmacol; 2018 Aug; 61():266-276. PubMed ID: 29902710
[TBL] [Abstract][Full Text] [Related]
36. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
37. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
38. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
[TBL] [Abstract][Full Text] [Related]
40. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Jun; 83():106445. PubMed ID: 32272395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
